江蘇陽光(600220.SH):聘任高青化為總經理、陸宇為董事長及法人
格隆匯3月13日丨江蘇陽光(600220.SH)公佈,公司董事會於今日收到公司董事長、總經理繆鋒遞交的書面辭職報吿。繆鋒因個人原因,申請辭去公司董事長、董事、總經理、法定代表人的職務。
為保證公司董事會的日常運作及公司經營工作的正常開展,公司於2023年3月13日召開的第八屆董事會第十八次會議審議通過了《關於選舉公司董事長的議案》、《關於聘任公司總經理的議案》,公司董事會同意選舉陸宇為公司董事長,並擔任公司法定代表人;同意聘任高青化為公司總經理。任期至第八屆董事會期滿。高青化擔任公司總經理後,不再擔任公司副總經理。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.